GlassScriptPhysician profile
Raneat Cohen
NPI 1407017155
$539.73
in general payments reported to CMS, 2019-2025
9 companies · $143 in 2025
The $143 reported for 2025 was less than what a typical Corneal and Contact Management provider received nationally (typical 2025 total: $227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2021: $28.70 · 2022: $77.85 · 2023: $147 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $289.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $99.73 | 2025 | Xiidra, Miebo |
| Sun Pharmaceutical Industries INC. | $85.72 | 2019-2025 | |
| Shire North American Group INC | $84.55 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $75.94 | 2023 | Acuvue |
| Alcon Vision LLC | $69.03 | 2022-2023 | Clareon |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $46.27 | 2019-2021 | |
| Abbvie INC. | $32.30 | 2022-2023 | Ozurdex |
| Novartis Pharmaceuticals Corporation | $29.14 | 2023 | |
| Iridex Corporation | $17.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raneat Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.